📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis (2020)

First Author: Oliveira-Da-Silva J

Attributed to: VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cellimm.2020.104194

PubMed Identifier: 32827943

Publication URI: http://europepmc.org/abstract/MED/32827943

Type: Journal Article/Review

Parent Publication: Cellular Immunology

ISSN: 0008-8749